While medical device industry leaders' love lives aren't usually a part of our coverage on Medtech Pulse, we admit we (and everyone else) were intrigued by the Wall Street Journal's article this week positing that Stryker CEO Stephen MacMillan's abrupt resignation last month was tied to some titillating gossip. The WSJ reported that MacMillan's resignation—which was attributed publicly to "family reasons"— came on the heels of board members learning of MacMillan's affair with an ex-employee while he was involved in divorce proceedings. In other news, an e-mail has surfaced indicating that J&J was aware early on of high revision rates and problems with the DePuy ASR all-metal hip implant. The implant was later recalled and subsequent controversy ensued. Read about these and more of the week's top medtech stories in our weekly roundup below.

• Behind a CEO's Departure: An Ouster or Resignation (Wall Street Journal)
• Hip Implant Had Early Warning Failure Signs (Qmed)
• Artificial Pancreas, Injection Sites, and Fast-Acting Insulin: Diabetes Trends and Challenges (MD+DI)
• Medical Device Loophole Needs Closing by Congress, FDA Device Chief Says (Bloomberg)
• Device Hacking Continues: Medtronic, Others 'Lacked Foresight' (MPMN)
• A Google Maps Glimpse of the Impact of the Medical Device Tax (MedCity News)
• Medical Device Makers Gain Political Momentum (Minneapolis StarTribune)
• Medical Device Companies Feel Economic Pressure, See Record M&A Levels (Healthcare Finance News)
• Qmed Partners with onTarget Jobs to Provide Medical Device Professionals and Employers with Career Services Tool (Qmed)
• EMDT Introduces MEDTEC Connection Site (medtechinsider)
• Q&A with Jay Pierce, CEO of OrthoSensor (MedGadget)
• Pills as Good as Stents for Some Patients (Reuters)